What is Alimetrix?
Alimetrix is dedicated to advancing diagnostic tools for infectious disease treatment, aiming to deliver state-of-the-art assays with exceptional accuracy and timeliness. The company's mission is to equip clinicians with high-quality diagnostic information, thereby improving patient recovery outcomes. Headquartered in Huntsville, Alabama, Alimetrix leverages a sophisticated repertoire of technologies tailored to specific assay targets, offering its platform across the U.S. The company's focus on actionable, relevant diagnostic information highlights its commitment to innovation in the healthcare sector.
How much funding has Alimetrix raised?
Alimetrix has raised a total of $61K across 1 funding round:
Debt
$61K
Debt (2021): $61K with participation from PPP
Key Investors in Alimetrix
PPP
Public-Private Partnership
What's next for Alimetrix?
With the recent influx of substantial expansion capital, Alimetrix is poised for significant scaling and further development of its diagnostic platform. The company's Series B/C stage funding suggests a strategic focus on market penetration, potential product line expansion, and strengthening its technological infrastructure. This investment is expected to fuel Alimetrix's ability to meet the growing demand for accurate and timely infectious disease diagnostics, reinforcing its position as a key player in the healthcare technology landscape.
See full Alimetrix company page
